Commonwealth Bank of Australia’s BioCryst Pharmaceuticals BCRX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2014 Q2	–	Sell	-30,550	Closed	-$323K	–	814
2014 Q1	$323K	Buy	30,550 +900	+3%	+$9.52K	﹤0.01%	1141
2013 Q4	$225K	Buy	29,650 +15,650	+112%	+$119K	﹤0.01%	1165
2013 Q3	$102K	Buy	+14,000	New	+$102K	﹤0.01%	1186